Journal
ONCOLOGY-NEW YORK
Volume 33, Issue 3, Pages 91-100Publisher
UBM MEDICA
Keywords
-
Categories
Funding
- NCI NIH HHS [P50 CA221747] Funding Source: Medline
- NINDS NIH HHS [R00 NS082381, K99 NS082381, R01 NS097851, F32 NS073366] Funding Source: Medline
Ask authors/readers for more resources
Glioblastoma is an aggressive primary tumor of the central nervous system. This review will focus on clinical developments and management of newly diagnosed disease, including a discussion about the incorporation of molecular features into the classification of glioblastoma. Such advances will continue to shape our thinking about the disease and how to best manage it. With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumortreating fields will be presented. Pivotal studies defining our current standard of care will be highlighted, as will key ongoing trials that may influence our management of glioblastoma in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available